Page last updated: 2024-11-07

4-methylcholest-7-en-3-ol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

4-methylcholest-7-en-3-ol: RN given refers to (3beta,4alpha,5alpha)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID50990062
MeSH IDM0052261

Synonyms (4)

Synonym
4-methylcholest-7-en-3-ol
4-alpha-methyl-5-alpha-cholest-7-en-3-beta-ol
(1r,2s,5s,6s,7s,11r,15r)-2,6,15-trimethyl-14-[(2r)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-9-en-5-ol
4-a-methyl-5-a-cholest-7-en-3-b-ol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (2)

PathwayProteinsCompounds
cholesterol biosynthesis (plants)1417
cholesterol biosynthesis (plants, early side-chain reductase)117

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (62.50)18.7374
1990's2 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]